{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:52:54Z","timestamp":1777611174587,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T00:00:00Z","timestamp":1721001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T00:00:00Z","timestamp":1721001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s10072-024-07669-4","type":"journal-article","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T05:01:22Z","timestamp":1721019682000},"page":"365-379","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Progressive multifocal leukoencephalopathy and spectrum of predisposing conditions: a 20-year retrospective cohort study in a tertiary center in S\u00e3o Paulo, Brazil"],"prefix":"10.1007","volume":"46","author":[{"given":"Julia Ferreira","family":"Mari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9rique Jos\u00e9 Farias Peixoto","family":"de Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Cassia","family":"Mendes-Correa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felicia C.","family":"Chow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7830-8716","authenticated-orcid":false,"given":"Jos\u00e9 Ernesto","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,15]]},"reference":[{"key":"7669_CR1","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1128\/CMR.05031-11","volume":"25","author":"MW Ferenczy","year":"2012","unstructured":"Ferenczy MW, Marshall LJ, Nelson CD et al (2012) Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev 25:471\u2013506. https:\/\/doi.org\/10.1128\/CMR.05031-11","journal-title":"Clin Microbiol Rev"},{"key":"7669_CR2","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/s13365-023-01164-w","volume":"29","author":"A Rocchi","year":"2023","unstructured":"Rocchi A, Sariyer IK, Berger JR (2023) Revisiting JC virus and progressive multifocal leukoencephalopathy. J Neurovirol 29:524\u2013537. https:\/\/doi.org\/10.1007\/s13365-023-01164-w","journal-title":"J Neurovirol"},{"key":"7669_CR3","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jns.2017.09.002","volume":"381","author":"MA Lima","year":"2017","unstructured":"Lima MA, Silva MTT, Afonso LA, Vaz BJP (2017) Post-cART progressive multifocal leukoencephalopathy era in a Brazilian center. J Neurol Sci 381:321\u2013324. https:\/\/doi.org\/10.1016\/j.jns.2017.09.002","journal-title":"J Neurol Sci"},{"key":"7669_CR4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/brain\/81.1.93","volume":"81","author":"KE Astrom","year":"1958","unstructured":"Astrom KE, Mancall EL, Richardson EP Jr (1958) Progressive multifocal leukoencephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin\u2019s disease. Brain 81:93\u2013111. https:\/\/doi.org\/10.1093\/brain\/81.1.93","journal-title":"Brain"},{"key":"7669_CR5","doi-asserted-by":"publisher","first-page":"1146027","DOI":"10.3389\/fneur.2023.1146027","volume":"14","author":"JR Berger","year":"2023","unstructured":"Berger JR, Hartung HP (2023) Commentary: Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies. Front Neurol 14:1146027. https:\/\/doi.org\/10.3389\/fneur.2023.1146027","journal-title":"Front Neurol"},{"issue":"Suppl 1","key":"7669_CR6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1080\/13550280390195397","volume":"9","author":"SK Shankar","year":"2003","unstructured":"Shankar SK, Satishchandra P, Mahadevan A et al (2003) Low prevalence of progressive multifocal leukoencephalopathy in India and Africa: is there a biological explanation? J Neurovirol 9(Suppl 1):59\u201367. https:\/\/doi.org\/10.1080\/13550280390195397","journal-title":"J Neurovirol"},{"issue":"4","key":"7669_CR7","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s13365-019-00746-x","volume":"25","author":"E Mubanga","year":"2019","unstructured":"Mubanga E, Patel A, Siddiqi OK et al (2019) Progressive multifocal leukoencephalopathy in Zambia is caused by JC virus with prototype regulatory region. J Neurovirol 25(4):475\u20139. https:\/\/doi.org\/10.1007\/s13365-019-00746-x","journal-title":"J Neurovirol"},{"issue":"1","key":"7669_CR8","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jcv.2010.02.020","volume":"48","author":"MC Fink","year":"2010","unstructured":"Fink MC, de Oliveira AC, Romano CM et al (2010) Molecular characterization of human polyomavirus JC in Brazilian AIDS patients with and without progressive multifocal leukoencephalopathy. J Clin Virol. 48(1):6\u201310. https:\/\/doi.org\/10.1016\/j.jcv.2010.02.020","journal-title":"J Clin Virol."},{"issue":"3","key":"7669_CR9","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s13365-013-0168-8","volume":"19","author":"M Netravathi","year":"2013","unstructured":"Netravathi M, Mahadevan A, Satishchandra P et al (2013) Progressive multifocal leukoencephalopathy (PML) associated with HIV Clade C\u2013is not uncommon. J Neurovirol. 19(3):198\u2013208. https:\/\/doi.org\/10.1007\/s13365-013-0168-8","journal-title":"J Neurovirol."},{"key":"7669_CR10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1080\/25787489.2021.1975609","volume":"22","author":"JP Telles","year":"2021","unstructured":"Telles JP, Fernandes R, Barros TD et al (2021) Neurological manifestations in people living with HIV\/AIDS in the late cART era: a prospective observational study at a tertiary healthcare center in S\u00e3o Paulo, Brazil. HIV Res Clin Pract 22:87\u201395","journal-title":"HIV Res Clin Pract"},{"issue":"1","key":"7669_CR11","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/brain\/awac237","volume":"146","author":"M Joly","year":"2023","unstructured":"Joly M, Conte C, Cazanave C et al (2023) Progressive multifocal leukoencephalopathy: epidemiology and spectrum of predisposing conditions. Brain. 146(1):349\u201358. https:\/\/doi.org\/10.1093\/brain\/awac237","journal-title":"Brain."},{"key":"7669_CR12","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1212\/WNL.0b013e31828c2fa1","volume":"80","author":"JR Berger","year":"2013","unstructured":"Berger JR, Aksamit AJ, Clifford DB et al (2013) PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section. Neurology 80:1430\u20131438. https:\/\/doi.org\/10.1212\/WNL.0b013e31828c2fa1","journal-title":"Neurology"},{"key":"7669_CR13","doi-asserted-by":"publisher","first-page":"e498","DOI":"10.1212\/WNL.0000000000004926","volume":"90","author":"E Iacobaeus","year":"2018","unstructured":"Iacobaeus E, Burkill S, Bahmanyar S et al (2018) The national incidence of PML in Sweden, 1988\u20132013. Neurology 90:e498\u2013e506. https:\/\/doi.org\/10.1212\/WNL.0000000000004926","journal-title":"Neurology"},{"key":"7669_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1086\/595299","volume":"199","author":"FN Engsig","year":"2009","unstructured":"Engsig FN, Hansen AB, Omland LH et al (2009) Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study. J Infect Dis 199:77\u201383. https:\/\/doi.org\/10.1086\/595299","journal-title":"J Infect Dis"},{"key":"7669_CR15","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1212\/01.wnl.0000233918.21986.9c","volume":"67","author":"PM Eng","year":"2006","unstructured":"Eng PM, Turnbull BR, Cook SF et al (2006) Characteristics and antecedents of progressive multifocal leukoencephalopathy in an insured population. Neurology 67:884\u2013886. https:\/\/doi.org\/10.1212\/01.wnl.0000233918.21986.9c","journal-title":"Neurology"},{"key":"7669_CR16","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1212\/WNL.0b013e3181c0d4a1","volume":"73","author":"A Marzocchetti","year":"2009","unstructured":"Marzocchetti A, Tompkins T, Clifford DB et al (2009) Determinants of survival in progressive multifocal leukoencephalopathy. Neurology 73:1551\u20131558. https:\/\/doi.org\/10.1212\/WNL.0b013e3181c0d4a1","journal-title":"Neurology"},{"key":"7669_CR17","doi-asserted-by":"publisher","first-page":"3761","DOI":"10.1002\/art.24966","volume":"60","author":"ES Molloy","year":"2009","unstructured":"Molloy ES, Calabrese LH (2009) Progressive multifocal leukoencephalopathy: a national estimate of frequency in systemic lupus erythematosus and other rheumatic diseases. Arthritis Rheum 60:3761\u20133765. https:\/\/doi.org\/10.1002\/art.24966","journal-title":"Arthritis Rheum"},{"key":"7669_CR18","doi-asserted-by":"publisher","first-page":"e618","DOI":"10.1212\/NXI.0000000000000618","volume":"6","author":"P Anand","year":"2019","unstructured":"Anand P, Hotan GC, Vogel A et al (2019) Progressive multifocal leukoencephalopathy: A 25-year retrospective cohort study. Neurol Neuroimmunol Neuroinflamm 6:e618. https:\/\/doi.org\/10.1212\/NXI.0000000000000618","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"7669_CR19","doi-asserted-by":"publisher","first-page":"ofz024","DOI":"10.1093\/ofid\/ofz024","volume":"6","author":"M Kartau","year":"2019","unstructured":"Kartau M, Verkkoniemi-Ahola A, Paetau A et al (2019) The incidence and predisposing factors of john cunningham virus-induced progressive multifocal leukoencephalopathy in Southern Finland: a population-based study. Open Forum Infect Dis 6:ofz024. https:\/\/doi.org\/10.1093\/ofid\/ofz024","journal-title":"Open Forum Infect Dis"},{"key":"7669_CR20","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2147\/DNND.S203405","volume":"9","author":"M Kartau","year":"2019","unstructured":"Kartau M, Sipil\u00e4 JO, Auvinen E et al (2019) Progressive multifocal leukoencephalopathy: current insights. Degener Neurol Neuromuscul Dis 9:109\u2013121. https:\/\/doi.org\/10.2147\/DNND.S203405","journal-title":"Degener Neurol Neuromuscul Dis"},{"key":"7669_CR21","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00415-018-09167-y","volume":"266","author":"JOT Sipil\u00e4","year":"2019","unstructured":"Sipil\u00e4 JOT, Soilu-H\u00e4nninen M, Rautava P et al (2019) Progressive multifocal leukoencephalopathy in Finland: a cross-sectional registry study. J Neurol 266:515\u2013521. https:\/\/doi.org\/10.1007\/s00415-018-09167-y","journal-title":"J Neurol"},{"key":"7669_CR22","doi-asserted-by":"publisher","first-page":"968","DOI":"10.3390\/v15040968","volume":"15","author":"K Nakamichi","year":"2023","unstructured":"Nakamichi K, Miura Y, Shimokawa T et al (2023) Nationwide laboratory surveillance of progressive multifocal leukoencephalopathy in Japan: fiscal years 2011\u20132020. Viruses 15:968. https:\/\/doi.org\/10.3390\/v15040968","journal-title":"Viruses"},{"key":"7669_CR23","doi-asserted-by":"publisher","first-page":"14291","DOI":"10.1038\/s41598-023-41147-9","volume":"13","author":"J Kim","year":"2023","unstructured":"Kim J, Kim C, Lee JA et al (2023) Long-term prognosis and overall mortality in patients with progressive multifocal leukoencephalopathy. Sci Rep 13:14291. https:\/\/doi.org\/10.1038\/s41598-023-41147-9","journal-title":"Sci Rep"},{"key":"7669_CR24","doi-asserted-by":"publisher","first-page":"632535","DOI":"10.3389\/fneur.2021.632535","volume":"12","author":"LM Graf","year":"2021","unstructured":"Graf LM, Rosenkranz SC, H\u00f6lzemer A et al (2021) Clinical Presentation and Disease Course of 37 Consecutive Cases of Progressive Multifocal Leukoencephalopathy (PML) at a German tertiary-care hospital: a retrospective observational study. Front Neurol 12:632535. https:\/\/doi.org\/10.3389\/fneur.2021.632535","journal-title":"Front Neurol"},{"key":"7669_CR25","unstructured":"Minist\u00e9rio da Sa\u00fade do Brasil. Secretaria de Vigil\u00e2ncia em Sa\u00fade Departamento de Doen\u00e7as de Condi\u00e7\u00f5es Cr\u00f4nicas e Infec\u00e7\u00f5es Sexualmente Transmiss\u00edveis. Relat\u00f3rio de Monitoramento Cl\u00ednico do HIV 2022. Available at: https:\/\/www.gov.br\/aids\/pt-br\/central-de-conteudo\/publicacoes\/2022\/relatoriode-monitoramento-clinico-do-hiv-setembro-2022.pdf\/view. Accessed in May 20, 2024."},{"key":"7669_CR26","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1056\/NEJMoa054693","volume":"354","author":"TA Yousry","year":"2006","unstructured":"Yousry TA, Major EO, Ryschkewitsch C et al (2006) Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. N Engl J Med 354:924\u2013933. https:\/\/doi.org\/10.1056\/NEJMoa054693","journal-title":"N Engl J Med"},{"key":"7669_CR27","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/ana.22408","volume":"70","author":"FJ Mateen","year":"2011","unstructured":"Mateen FJ, Muralidharan R, Carone M et al (2011) Progressive multifocal leukoencephalopathy in transplant recipients. Ann Neurol 70:305\u2013322. https:\/\/doi.org\/10.1002\/ana.22408","journal-title":"Ann Neurol"},{"key":"7669_CR28","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s13365-014-0303-1","volume":"21","author":"S Chahin","year":"2015","unstructured":"Chahin S, Berger JR (2015) A risk classification for immunosuppressive treatment associated progressive multifocal leukoencephalopathy. J Neurovirol 21:623\u2013631. https:\/\/doi.org\/10.1007\/s13365-014-0303-1","journal-title":"J Neurovirol"},{"key":"7669_CR29","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/cpt.604","volume":"102","author":"R Anton","year":"2017","unstructured":"Anton R, Haas M, Arlett P et al (2017) Drug-induced progressive multifocal leukoencephalopathy in multiple sclerosis: European regulators\u2019 perspective. Clin Pharmacol Ther 102:283\u2013289. https:\/\/doi.org\/10.1002\/cpt.604","journal-title":"Clin Pharmacol Ther"},{"key":"7669_CR30","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1212\/WNL.0b013e318225ab3f","volume":"77","author":"IL Tan","year":"2011","unstructured":"Tan IL, Koralnik IJ, Rumbaugh JA et al (2011) Progressive multifocal leukoencephalopathy in a patient without immunodeficiency. Neurology 77:297\u2013299. https:\/\/doi.org\/10.1212\/WNL.0b013e318225ab3f","journal-title":"Neurology"},{"key":"7669_CR31","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s13311-017-0570-7","volume":"14","author":"EML Williamson","year":"2017","unstructured":"Williamson EML, Berger JR (2017) Diagnosis and treatment of progressive multifocal leukoencephalopathy associated with multiple sclerosis therapies. Neurotherapeutics 14:961\u2013973. https:\/\/doi.org\/10.1007\/s13311-017-0570-7","journal-title":"Neurotherapeutics"},{"key":"7669_CR32","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/B978-0-444-53488-0.00017-1","volume":"123","author":"JR Berger","year":"2014","unstructured":"Berger JR (2014) Progressive multifocal leukoencephalopathy. Handb Clin Neurol 123:357\u2013376. https:\/\/doi.org\/10.1016\/B978-0-444-53488-0.00017-1","journal-title":"Handb Clin Neurol"},{"issue":"Suppl 2","key":"7669_CR33","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3949\/ccjm.78.s2.03","volume":"78","author":"JR Berger","year":"2011","unstructured":"Berger JR (2011) The clinical features of PML. Cleve Clin J Med. 78(Suppl 2):8\u201312. https:\/\/doi.org\/10.3949\/ccjm.78.s2.03","journal-title":"Cleve Clin J Med."},{"key":"7669_CR34","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1177\/1352458512463483","volume":"19","author":"A Harrer","year":"2013","unstructured":"Harrer A, Tumani H, Niendorf S et al (2013) Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy. Mult Scler 19:1209\u20131212. https:\/\/doi.org\/10.1177\/1352458512463483","journal-title":"Mult Scler"},{"key":"7669_CR35","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1136\/jnnp-2013-304897","volume":"84","author":"S Dahlhaus","year":"2013","unstructured":"Dahlhaus S, Hoepner R, Chan A et al (2013) Disease course and outcome of 15 monocentrically treated natalizumab-associated progressive multifocal leukoencephalopathy patients. J Neurol Neurosurg Psychiatry 84:1068\u20131074. https:\/\/doi.org\/10.1136\/jnnp-2013-304897","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-024-07669-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-024-07669-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-024-07669-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T11:06:11Z","timestamp":1735902371000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-024-07669-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,15]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["7669"],"URL":"https:\/\/doi.org\/10.1007\/s10072-024-07669-4","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,15]]},"assertion":[{"value":"24 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted according to the principles of the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was waived by the institutional Ethics Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}